Peng Huang

Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinoma

T. Zhu, P. Lobie, V. Pandey, 2022, Cell Death & Disease.

Therapeutic vulnerabilities in triple negative breast cancer: Stem-like traits explored within molecular classification.

J. Prabhu, Peng Huang, Xi Zhang, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach

Peng Huang, Tesfaye Wolde, Vijay Pandey, 2024, BioMedInformatics.

TFF3 and PVRL2 co-targeting identified by multi-omics approach as an effective cancer immunosuppression strategy.

Vipul Bhardwaj, Peng Huang, Tesfaye Wolde, 2024, Life sciences.